|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 569.77 USD | +0.04% |
|
+3.13% | -15.78% |
| 07-27 | Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says | MT |
| 07-27 | UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.04% | +3.13% | +3.31% | +0.26% | -15.78% | +0.58% | +3.07% | -18.09% | +511.28% | 44.95B | ||
| Average | +0.04% | +3.09% | +3.31% | +0.26% | -15.78% | +0.58% | +3.07% | -18.09% | +511.28% | 44.95B | |
| Weighted average by Cap. | +0.04% | +3.09% | +3.31% | +0.26% | -15.78% | +0.58% | +3.07% | -18.09% | +511.28% |
- Stock Market
- Stocks
- IDXX Stock
- Sector IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















